MUMBAI, India, March 13 -- Intellectual Property India has published a patent application (202611007289 A) filed by Maharishi Markandeshwar Deemed To Be University, Ambala, Haryana, on Jan. 24, for 'formulation and evaluation of anti-inflammatory efficacy of polyherbal tablet of nyctanthes arbor-tristis and moringa oleifera.'
Inventor(s) include Prof. Rina Das; Prof. Dinesh K. Mehta; Ayan Aggarwal; and Ashish Bhardwaj.
The application for the patent was published on March 13, under issue no. 11/2026.
According to the abstract released by the Intellectual Property India: "The present invention relates to the development of a polyherbal anti-inflammatory tablet comprising alcoholic leaf extracts of Nyctanthes arbor-tristis and Moringa oleifera in 1:1 ratio. The extracts were manufactured using standard extraction procedures and formulated into tablets by dry granulation. The formulation was assessed for pharmaceutical parameters, in-vitro dissolution, and stability. Evaluating Anti-inflammatory activity using the carrageenan induced paw edema model was performed, where the formulation exhibited significant and dose-dependent inhibition of inflammation. The alcoholic extract at 250 mg/kg produced approximately 34.96 % inhibition of paw edema, comparable to the standard drug diclofenac. The invention provides a stable, standardized, and effective polyherbal tablet for the management of inflammatory conditions."
Disclaimer: Curated by HT Syndication.
